Cardinal Health (CAH) Falls on Dismal Revenue Performance

We recently published 10 Stocks That Vanished in Value Cardinal Health, Inc. (NYSE:CAH) is one of the worst-performing stocks on Tuesday.

Cardinal Health dropped its share prices by 7.21 percent on Tuesday to finish at $146.3 apiece as investors soured on its dismal revenue performance in both the fourth quarter and the full fiscal period of 2025.

In its updated report, Cardinal Health, Inc. (NYSE:CAH) said revenues in the fourth quarter of the year finished flat at $60 billion, but attributable net income grew by 11 percent to $501 million from $450 million in the same period last year.

In the full fiscal year of 2025, revenues decreased by 2 percent to $222.6 billion from $226.8 billion last year. Attributable net income, however, grew by 7 percent to $2 billion from $1.9 billion year-on-year.

In other news, Cardinal Health, Inc. (NYSE:CAH) announced the acquisition of Solaris Health through its management services organization (MSO), The Specialty Alliance.

Under the transaction, Cardinal Health, Inc. (NYSE:CAH) will infuse $1.9 billion in cash into The Specialty Alliance, in turn, raising its ownership in the latter to approximately 75 percent.

Cardinal Health said it expects the transaction to close by the end of the year, subject to closing conditions, including the receipt of required physician and regulatory approvals.

While we acknowledge the potential of CAH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.